Amgen Data Breach Exposes Sensitive Info of Affiliated Individuals

Amgen, a California-based biotechnology company, is under investigation for a data breach that occurred in July 2026. The breach led to unauthorized access to sensitive information of individuals affiliated with Amgen.

The company disclosed the incident in its Securities and Exchange Commission (SEC) Form 8-K filing, describing it as 'material.' However, Amgen has not revealed the number of individuals impacted by the breach.

According to the filing, the compromised data may include proprietary information, patient protected health information, and other sensitive details. Although the breach occurred in July 2026, Amgen has yet to directly notify affected individuals, potentially violating state and federal laws.